The fall in revenue was driven by competitor discounts and an increase in coverage denials and delays by healthcare payors. The device company will release its third quarter financial results later this month.
More Articles on Orthopedic Devices:
13 Spine Devices Receive FDA 510(k) Clearance in September
How A Facility Implements Generic Orthopedic Implants
Pinnacle Spine Group Wins FDA Approval for Direct Lateral System
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.